One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes
Watch out for these red flags: providers who can't show proper licensing, services that seem suspiciously cheap (quality ingredients and trained staff cost money), anyone making unrealistic promises about results, or lack of clear medical oversight
RIPK1 plays multiple roles, such as mediating nuclear factor-kappa B (NF-B) activation, caspase-dependent apoptosis, and RIPK3-dependent necroptosis in response to activation signals
These medications may be a way to enhance behavioral change, she says
Frequently Asked Questions What is the difference between liposomal glutathione and standard oral glutathione